Levin Capital Strategies’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $346K | Buy |
140,000
+105,000
| +300% | +$259K | 0.03% | 135 |
|
|
2025
Q1 | $69.7K | Sell |
35,000
-40,000
| -53% | -$79.6K | 0.01% | 164 |
|
|
2024
Q4 | $219K | Buy |
75,000
+45,000
| +150% | +$131K | 0.02% | 172 |
|
|
2024
Q3 | $116K | Buy |
+30,000
| New | +$116K | 0.01% | 185 |
|
|
2024
Q2 | – | Sell |
-26,500
| Closed | -$186K | – | 243 |
|
|
2024
Q1 | $186K | Buy |
26,500
+6,500
| +33% | +$45.5K | 0.02% | 187 |
|
|
2023
Q4 | $177K | Buy |
+20,000
| New | +$177K | 0.02% | 180 |
|
|
2023
Q3 | – | Sell |
-20,000
| Closed | -$293K | – | 273 |
|
|
2023
Q2 | $293K | Buy |
+20,000
| New | +$293K | 0.03% | 168 |
|
|
2023
Q1 | – | Sell |
-10,585
| Closed | -$197K | – | 253 |
|
|
2022
Q4 | $197K | Buy |
+10,585
| New | +$197K | 0.03% | 181 |
|